[go: up one dir, main page]

WO2006009699A3 - Ciblage de tissus pulmonaires endommages - Google Patents

Ciblage de tissus pulmonaires endommages Download PDF

Info

Publication number
WO2006009699A3
WO2006009699A3 PCT/US2005/020993 US2005020993W WO2006009699A3 WO 2006009699 A3 WO2006009699 A3 WO 2006009699A3 US 2005020993 W US2005020993 W US 2005020993W WO 2006009699 A3 WO2006009699 A3 WO 2006009699A3
Authority
WO
WIPO (PCT)
Prior art keywords
targeting
lung tissue
damaged lung
compositions
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/020993
Other languages
English (en)
Other versions
WO2006009699A2 (fr
Inventor
Glen Gong
Ronald Dieck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PneumRx LLC
Original Assignee
PneumRx LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/008,094 external-priority patent/US20050281798A1/en
Priority claimed from US11/008,649 external-priority patent/US20050281739A1/en
Priority claimed from US11/008,093 external-priority patent/US7608579B2/en
Priority claimed from US11/008,092 external-priority patent/US20050281796A1/en
Priority claimed from US11/008,777 external-priority patent/US20050281740A1/en
Priority claimed from US11/008,782 external-priority patent/US7553810B2/en
Priority claimed from US11/008,580 external-priority patent/US7468350B2/en
Priority claimed from US11/008,087 external-priority patent/US7678767B2/en
Priority to EP05786087A priority Critical patent/EP1776139A4/fr
Application filed by PneumRx LLC filed Critical PneumRx LLC
Priority to JP2007516650A priority patent/JP2008503465A/ja
Publication of WO2006009699A2 publication Critical patent/WO2006009699A2/fr
Anticipated expiration legal-status Critical
Publication of WO2006009699A3 publication Critical patent/WO2006009699A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention concerne des méthodes et des compositions permettant de cibler des tissus pulmonaires endommagés. Les compositions de cette invention renferment une fraction de ciblage couplée à une ou plusieurs autres fractions, telles qu'une fraction réticulable, une fraction d'imagerie et/ou une ou plusieurs autres fractions de ciblage. Les méthodes et compositions de cette invention servent par exemple à détecter et à traiter un état pulmonaire tel qu'un emphysème.
PCT/US2005/020993 2004-06-16 2005-06-13 Ciblage de tissus pulmonaires endommages Ceased WO2006009699A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05786087A EP1776139A4 (fr) 2004-06-16 2005-06-13 Ciblage de tissus pulmonaires endommages
JP2007516650A JP2008503465A (ja) 2004-06-16 2005-06-13 損傷を受けた肺組織のターゲティング

Applications Claiming Priority (26)

Application Number Priority Date Filing Date Title
US58044404P 2004-06-16 2004-06-16
US60/580,444 2004-06-16
US58693204P 2004-07-08 2004-07-08
US58695004P 2004-07-08 2004-07-08
US60/586,932 2004-07-08
US60/586,950 2004-07-08
US11/008,093 2004-12-08
US11/008,578 2004-12-08
US11/008,782 US7553810B2 (en) 2004-06-16 2004-12-08 Lung volume reduction using glue composition
US11/008,649 2004-12-08
US11/008,580 US7468350B2 (en) 2004-06-16 2004-12-08 Glue composition for lung volume reduction
US11/008,649 US20050281739A1 (en) 2004-06-16 2004-12-08 Imaging damaged lung tissue using compositions
US11/008,094 2004-12-08
US11/008,777 2004-12-08
US11/008,087 2004-12-08
US11/008,777 US20050281740A1 (en) 2004-06-16 2004-12-08 Imaging damaged lung tissue
US11/008,094 US20050281798A1 (en) 2004-06-16 2004-12-08 Targeting sites of damaged lung tissue using composition
US11/008,092 2004-12-08
US11/008,782 2004-12-08
US11/008,578 US20050281800A1 (en) 2004-06-16 2004-12-08 Targeting sites of damaged lung tissue
US11/008,577 2004-12-08
US11/008,087 US7678767B2 (en) 2004-06-16 2004-12-08 Glue compositions for lung volume reduction
US11/008,092 US20050281796A1 (en) 2004-06-16 2004-12-08 Targeting damaged lung tissue
US11/008,577 US20050281799A1 (en) 2004-06-16 2004-12-08 Targeting damaged lung tissue using compositions
US11/008,093 US7608579B2 (en) 2004-06-16 2004-12-08 Lung volume reduction using glue compositions
US11/008,580 2004-12-08

Publications (2)

Publication Number Publication Date
WO2006009699A2 WO2006009699A2 (fr) 2006-01-26
WO2006009699A3 true WO2006009699A3 (fr) 2007-03-22

Family

ID=35785650

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/020993 Ceased WO2006009699A2 (fr) 2004-06-16 2005-06-13 Ciblage de tissus pulmonaires endommages

Country Status (3)

Country Link
EP (1) EP1776139A4 (fr)
JP (1) JP2008503465A (fr)
WO (1) WO2006009699A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080067687A (ko) * 2005-11-02 2008-07-21 아이리스 테라퓨틱스, 인코포레이티드 폴리양이온-폴리음이온 착물, 조성물, 및 이의 사용방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086852A1 (en) * 1998-05-14 2002-07-04 Cantor Jerome O. Method for treating respiratory disorders associated with pulmonary elastic fiber injury
US6565842B1 (en) * 1995-06-07 2003-05-20 American Bioscience, Inc. Crosslinkable polypeptide compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6565842B1 (en) * 1995-06-07 2003-05-20 American Bioscience, Inc. Crosslinkable polypeptide compositions
US20020086852A1 (en) * 1998-05-14 2002-07-04 Cantor Jerome O. Method for treating respiratory disorders associated with pulmonary elastic fiber injury

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
INGENITO E.P.: "Bronchoscopic Lung Volume Reduction Using Tissue Engineering Principles", AMER. J. RESP. AND CRIT. CARE MED., vol. 167, 2003, pages 771 - 778, XP003009383 *
INGENITO E.P.: "Bronchoscopic Volume Reduction, A Safe and Effective Alternative to Surgical Therapy for Emphysema", AMER. J. RESP. AND CRIT. CARE MED., vol. 164, 2001, pages 295 - 301, XP003009382 *
See also references of EP1776139A4 *

Also Published As

Publication number Publication date
EP1776139A2 (fr) 2007-04-25
EP1776139A4 (fr) 2009-08-19
WO2006009699A2 (fr) 2006-01-26
JP2008503465A (ja) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2006009682A3 (fr) Compositions de colle pour reduire le volume de poumons
WO2003093269A3 (fr) Pyrazolopyrimidine-4-one substituee
WO2008136865A3 (fr) (s)-n-stéréoisomères d'analogues de 4,5-époxy-morphinanium saturés en 7,8
WO2005122870A3 (fr) Dispositif d'acces au poumon
WO2008001101A3 (fr) Combinaisons pharmaceutiques
WO2008103935A3 (fr) Nouvelles compositions de tabac et leurs procédés de fabrication
WO2008042231A3 (fr) Compositions et méthodes d'évaluation et de traitement de l'insuffisance cardiaque
WO2008133663A3 (fr) Compositions immunogènes à codons modifiés et procédés d'utilisation
WO2005108358A3 (fr) Inhibiteurs de la bace
WO2008112022A8 (fr) Inhibiteurs de l'époxyde hydrolase soluble
WO2008106646A3 (fr) Procédés et formulations pour une thérapie génique topique
WO2007149287A3 (fr) Compositions de facteur de transfert et méthodes
IL239399A0 (en) Methods and compounds for the treatment of tumors, fibrosis and proteinosis of the lung nadia
WO2001087295A8 (fr) Procedes permettant de reduire la proliferation cellulaire fondes sur des acides (3r, 4r)-δdelta8-tetrahydrocannabinol-11-oiques
WO2008090193A3 (fr) Procédé pour produire des bêtamimétiques
WO2007112279A3 (fr) Résonateurs
CA2659376C (fr) 2,4-diaminoquinazolines contre l'amyotrophie spinale
WO2008073623A3 (fr) Inhibiteurs d'hydrolase epoxyde soluble
WO2009035959A3 (fr) Methodes de radiofluoration
WO2006119309A3 (fr) Composes de 19,26,27-trinor-1$g(a), 25-dihydroxyvitamine d3
WO2006086613A3 (fr) 2-methylene-19-nor- (20s-24s) - 1?, 25-d hydroxyvitamine-d2
WO2007117665A3 (fr) Analyse par derivation optimisee d'aminoacides et peptides
WO2006009699A3 (fr) Ciblage de tissus pulmonaires endommages
WO2006078975A3 (fr) Vaccin ameliore contre le calicivirus felin
WO2008083191A3 (fr) Procédés de radiofluoration

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007516650

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005786087

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005786087

Country of ref document: EP